Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Tradescantia pallida extract inhibits biofilm formation in Pseudomonas aeruginosa.

Kamiya M, Mori T, Nomura M, Inagaki T, Nonogaki T, Nagatsu A, Yamagishi Y, Mikamo H, Ikeda Y.

Nagoya J Med Sci. 2019 Aug;81(3):439-452. doi: 10.18999/nagjms.81.3.439.

2.

Retrospective study on clinical efficacy and safety for daptomycin intermittent doses with or without loading dose in renal failure patients.

Kato H, Hagihara M, Shibata Y, Asai N, Koizumi Y, Watarai M, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Sep 28. pii: S1341-321X(19)30276-4. doi: 10.1016/j.jiac.2019.09.004. [Epub ahead of print]

PMID:
31575501
3.

Relationship between cytopenia and gestational age in infants and neonates treated with linezolid therapy.

Shibata Y, Hagihara M, Kato H, Asai N, Koizumi Y, Watarai M, Suematsu H, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Aug 23. pii: S1341-321X(19)30233-8. doi: 10.1016/j.jiac.2019.07.022. [Epub ahead of print]

PMID:
31447138
4.

Current status of post-operative infections due to antimicrobial-resistant bacteria after digestive tract surgery in Japan: Japan Postoperative Infectious Complications Survey in 2015 (JPICS'15).

Hagihara M, Kusachi S, Kato Y, Yamagishi Y, Niitsuma T, Mikamo H, Takesue Y, Sumiyama Y.

Surg Today. 2019 Aug 9. doi: 10.1007/s00595-019-01857-y. [Epub ahead of print]

PMID:
31399783
5.

Comparison of in vivo activity of garenoxacin and levofloxacin in a murine pneumonia mixed-infection model by Streptococcus pneumoniae and Parvimonas micra.

Kato H, Hagihara M, Yokoyama Y, Suematsu H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

Jpn J Infect Dis. 2019 Jul 31. doi: 10.7883/yoken.JJID.2019.109. [Epub ahead of print]

6.

The SOFA score could predict the severity and prognosis of infective endocarditis.

Asai N, Shiota A, Ohashi W, Watanabe H, Shibata Y, Kato H, Sakanashi D, Hagihara M, Koizumi Y, Yamagishi Y, Suematsu H, Mikamo H.

J Infect Chemother. 2019 Jul 15. pii: S1341-321X(19)30146-1. doi: 10.1016/j.jiac.2019.05.014. [Epub ahead of print]

PMID:
31320197
7.

Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry.

Takahashi S, Murata K, Ozawa K, Yamada H, Kawakami H, Nakayama A, Asano Y, Mochizuki K, Mikamo H.

Jpn J Ophthalmol. 2019 Jul;63(4):328-336. doi: 10.1007/s10384-019-00669-4. Epub 2019 Jul 4.

PMID:
31273564
8.

Metronidazole-induced encephalopathy caused by hyperbaric oxygen therapy in a patient with mandibular osteomyelitis.

Yamamoto Y, Asai N, Furuhashi A, Ono T, Yamagishi Y, Mikamo H, Kazaoka Y.

J Infect Chemother. 2019 Jun 13. pii: S1341-321X(19)30158-8. doi: 10.1016/j.jiac.2019.05.022. [Epub ahead of print]

PMID:
31204183
9.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
10.

Current status of postoperative infections after digestive surgery in Japan: The Japan Postoperative Infectious Complications Survey in 2015.

Niitsuma T, Kusachi S, Takesue Y, Mikamo H, Asai K, Watanabe M.

Ann Gastroenterol Surg. 2019 Mar 12;3(3):276-284. doi: 10.1002/ags3.12236. eCollection 2019 May.

11.

The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia.

Ueda T, Takesue Y, Tokimatsu I, Miyazaki T, Nakada-Motokawa N, Nagao M, Nakajima K, Mikamo H, Yamagishi Y, Kasahara K, Yoshihara S, Ukimura A, Yoshida K, Yoshinaga N, Izumi M, Kakeya H, Yamada K, Kawamura H, Endou K, Yamanaka K, Yoshioka M, Amino K, Ikeuchi H, Uchino M, Miyazaki Y.

PLoS One. 2019 May 23;14(5):e0216956. doi: 10.1371/journal.pone.0216956. eCollection 2019.

12.

The impact of probiotic Clostridium butyricum MIYAIRI 588 on murine gut metabolic alterations.

Hagihara M, Yamashita R, Matsumoto A, Mori T, Inagaki T, Nonogaki T, Kuroki Y, Higashi S, Oka K, Takahashi M, Mikamo H.

J Infect Chemother. 2019 Aug;25(8):571-577. doi: 10.1016/j.jiac.2019.02.008. Epub 2019 May 14.

PMID:
31101528
13.

Feasibility of Trypsin Digestion as a Sample Preparation for Daptomycin Quantification in Murine Skeletal Muscles.

Sakai Y, Murakami E, Kato H, Ohyama K, Esaka Y, Yamamoto T, Hagihara M, Mikamo H, Uno B.

Biol Pharm Bull. 2019;42(5):751-757. doi: 10.1248/bpb.b18-00945.

14.

Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan.

Asai N, Sakanashi D, Suematsu H, Kato H, Watanabe H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Aug;25(8):639-642. doi: 10.1016/j.jiac.2019.03.016. Epub 2019 Apr 30.

PMID:
31053537
15.

Extended drip infusion of peripheral parental nutrition containing amino acids might be associated with Bacillus cereus bloodstream infection.

Shiota A, Asai N, Koizumi Y, Watanabe H, Sakata M, Kurumiya A, Takahashi T, Muramatsu Y, Hagihara M, Suematsu H, Yamagishi Y, Mikamo H.

Am J Infect Control. 2019 Sep;47(9):1154-1156. doi: 10.1016/j.ajic.2019.02.020. Epub 2019 Apr 30.

PMID:
31047689
16.

Infective endocarditis caused by Cardiobacterium hominis endocarditis: A case report and review of the literature.

Asai N, Sakanashi D, Suematsu H, Nishiyama N, Watanabe H, Kato H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Aug;25(8):626-629. doi: 10.1016/j.jiac.2019.02.002. Epub 2019 Apr 28.

PMID:
31043327
17.

Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia.

Asai N, Watanabe H, Shiota A, Kato H, Sakanashi D, Hagihara M, Koizumi Y, Yamagishi Y, Suematsu H, Mikamo H.

Int J Infect Dis. 2019 Jul;84:89-96. doi: 10.1016/j.ijid.2019.04.020. Epub 2019 Apr 24.

18.

Brevibacterium paucivorans bacteremia: case report and review of the literature.

Asai N, Suematsu H, Yamada A, Watanabe H, Nishiyama N, Sakanashi D, Kato H, Shiota A, Hagihara M, Koizumi Y, Yamagishi Y, Mikamo H.

BMC Infect Dis. 2019 Apr 25;19(1):344. doi: 10.1186/s12879-019-3962-y.

19.

Antimicrobial susceptibilities of clinical isolates of the anaerobic bacteria which can cause aspiration pneumonia.

Fujita K, Takata I, Sugiyama H, Suematsu H, Yamagishi Y, Mikamo H.

Anaerobe. 2019 Jun;57:86-89. doi: 10.1016/j.anaerobe.2019.04.002. Epub 2019 Apr 2.

PMID:
30951830
20.

A Case Demonstrating the Cardio-Vascular Interaction by a New Cardio-Ankle Vascular Index During the Treatment of Concentric Hypertrophy.

Shimizu K, Tabata T, Kiyokawa H, Morinaga Y, Sato S, Mikamo H, Nakagami T, Iiduka T, Shirai K, Noro M.

Cardiol Res. 2019 Feb;10(1):54-58. doi: 10.14740/cr812. Epub 2019 Feb 24.

21.

A novel disk-based detection method with superior sensitivity for β-lactamase production in third-generation cephalosporin-resistant Enterobacteriaceae.

Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 May;25(5):330-336. doi: 10.1016/j.jiac.2018.12.008. Epub 2019 Feb 21.

PMID:
30797690
22.

Clostridioides difficile-related toxic megacolon after Cryptococcus neoformans cellulitis: A complex of two rare infections in an immunocompromised host.

Koizumi Y, Kachi A, Tsuboi K, Muto J, Watanabe H, Asai N, Nobata H, Shiota A, Kato H, Sakanashi D, Hagihara M, Yamagishi Y, Suematsu H, Banno S, Mikamo H.

J Infect Chemother. 2019 May;25(5):379-384. doi: 10.1016/j.jiac.2018.12.003. Epub 2019 Feb 21.

PMID:
30797689
23.

Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.

Mikamo H, Yamagishi Y, Murata S, Yokokawa R, Han SR, Wakana A, Sawata M, Tanaka Y.

Vaccine. 2019 Mar 14;37(12):1651-1658. doi: 10.1016/j.vaccine.2019.01.069. Epub 2019 Feb 20.

24.

Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature.

Asai N, Koizumi Y, Yamada A, Sakanashi D, Watanabe H, Kato H, Shiota A, Hagihara M, Suematsu H, Yamagishi Y, Mikamo H.

J Med Case Rep. 2019 Feb 13;13(1):33. doi: 10.1186/s13256-019-1969-z. Review.

25.

A severe case of Streptococcal pyogenes empyema following influenza A infection.

Asai N, Suematsu H, Sakanashi D, Kato H, Hagihara M, Watanabe H, Shiota A, Koizumi Y, Yamagishi Y, Mikamo H.

BMC Pulm Med. 2019 Jan 28;19(1):25. doi: 10.1186/s12890-019-0787-9.

26.

[Is BC-GN applicable for analysis of strains and urine/sputum specimens?]

Ohno T, Suematsu H, Yamagishi Y, Miyazaki N, Yamada A, Kawamoto Y, Sakanashi D, Koita I, Mikamo H.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2018 Dec 25;28(2):91-99. Japanese.

PMID:
30630335
27.

The efficacy and safety of tazobactam/ceftolozane in combination with metronidazole in Japanese patients with complicated intra-abdominal infections.

Mikamo H, Monden K, Miyasaka Y, Horiuchi T, Fujimoto G, Fukuhara T, Yoshinari T, Rhee EG, Shizuya T.

J Infect Chemother. 2019 Feb;25(2):111-116. doi: 10.1016/j.jiac.2018.10.012. Epub 2018 Dec 6.

28.

Antifungal susceptibility trend and analysis of resistance mechanism for Candida species isolated from bloodstream at a Japanese university hospital.

Sakagami T, Kawano T, Yamashita K, Yamada E, Fujino N, Kaeriyama M, Fukuda Y, Nomura N, Mitsuyama J, Suematsu H, Watanabe H, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Jan;25(1):34-40. doi: 10.1016/j.jiac.2018.10.007. Epub 2018 Nov 3.

PMID:
30401513
29.

Characterization of the vaginal microbiota of Japanese women.

Matsumoto A, Yamagishi Y, Miyamoto K, Oka K, Takahashi M, Mikamo H.

Anaerobe. 2018 Dec;54:172-177. doi: 10.1016/j.anaerobe.2018.10.001. Epub 2018 Oct 3.

PMID:
30291903
30.

Antimicrobial activity of solithromycin and levofloxacin against a murine pneumonia mixed-infection model caused by Streptococcus pneumoniae and anaerobic bacteria.

Kato H, Yamagishi Y, Hagihara M, Yokoyama Y, Suematsu H, Asai N, Koizumi Y, Mikamo H.

J Infect Chemother. 2019 Apr;25(4):311-313. doi: 10.1016/j.jiac.2018.09.003. Epub 2018 Oct 2.

PMID:
30287186
31.

A case of acute septic arthritis of the hip joint caused by Panton-Valentine leukocidin-positive ST772 community-acquired methicillin-resistant Staphylococcus aureus.

Takadama S, Yamagishi Y, Nakaminami H, Morishima T, Deie M, Mikamo H, Noguchi N.

J Infect Chemother. 2019 Mar;25(3):212-214. doi: 10.1016/j.jiac.2018.08.015. Epub 2018 Sep 11.

PMID:
30217733
32.

Association between Clostridioides difficile ribotypes, restriction endonuclease analysis types, and toxin gene expression.

Watanabe H, Koizumi Y, Matsumoto A, Asai N, Yamagishi Y, Mikamo H.

Anaerobe. 2018 Dec;54:140-143. doi: 10.1016/j.anaerobe.2018.09.002. Epub 2018 Sep 7.

PMID:
30201540
33.

Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.

Igarashi Y, Tashiro S, Enoki Y, Taguchi K, Matsumoto K, Ohge H, Suzuki H, Nakamura A, Mori N, Morinaga Y, Yamagishi Y, Yoshizawa S, Yanagihara K, Mikamo H, Kunishima H.

J Infect Chemother. 2018 Nov;24(11):907-914. doi: 10.1016/j.jiac.2018.08.003. Epub 2018 Aug 29.

PMID:
30170735
34.

In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group.

Yamagishi Y, Matsukawa Y, Suematsu H, Mikamo H.

Anaerobe. 2018 Dec;54:61-64. doi: 10.1016/j.anaerobe.2018.08.002. Epub 2018 Aug 13.

PMID:
30114441
35.

Effect of sodium mercaptoacetic acid on different antimicrobial disks in the sodium mercaptoacetic acid double disk synergy test for detection of IMP-1 metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Japan.

Sakanashi D, Miyazaki N, Kawamoto Y, Ohno T, Yamada A, Koita I, Miyajima S, Suematsu H, Hagihara M, Asai N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2019 Jan;25(1):75-77. doi: 10.1016/j.jiac.2018.07.005. Epub 2018 Aug 9.

PMID:
30100401
36.

Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium.

Koizumi Y, Sakagami T, Minamiguchi H, Makino A, Aoki A, Hodohara K, Mikamo H, Andoh A, Fujiyama Y.

Med Microbiol Immunol. 2019 Feb;208(1):33-37. doi: 10.1007/s00430-018-0555-0. Epub 2018 Aug 6.

PMID:
30083859
37.

The impact of Clostridium butyricum MIYAIRI 588 on the murine gut microbiome and colonic tissue.

Hagihara M, Yamashita R, Matsumoto A, Mori T, Kuroki Y, Kudo H, Oka K, Takahashi M, Nonogaki T, Yamagishi Y, Mikamo H.

Anaerobe. 2018 Dec;54:8-18. doi: 10.1016/j.anaerobe.2018.07.012. Epub 2018 Aug 1.

PMID:
30076897
38.

Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan.

Mikamo H, Tateda K, Yanagihara K, Kusachi S, Takesue Y, Miki T, Oizumi Y, Gamo K, Hashimoto A, Toyoshima J, Kato K.

J Infect Chemother. 2018 Sep;24(9):744-752. doi: 10.1016/j.jiac.2018.05.010. Epub 2018 Jun 19.

39.

Corrigendum to "Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan" [J Infect Chemother 24 (2018) 330-340].

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Nakajima K, Ueda T, Uchino M, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K.

J Infect Chemother. 2018 Jul;24(7):592-595. doi: 10.1016/j.jiac.2018.05.011. No abstract available.

PMID:
29887496
40.

Comparative study on safety of linezolid and vancomycin in the treatment of infants and neonates for Gram-positive bacterial infections.

Shibata Y, Yamagishi Y, Mikamo H, Kato H, Nishiyama N, Asai N, Koizumi Y, Matsuura K, Suematsu H, Hagihara M.

J Infect Chemother. 2018 Sep;24(9):695-701. doi: 10.1016/j.jiac.2018.04.006. Epub 2018 May 25.

PMID:
29807867
41.

The evaluation of frequency of nephrotoxicity caused by liposomal amphotericin B.

Kato H, Hagihara M, Yamagishi Y, Shibata Y, Kato Y, Furui T, Watanabe H, Asai N, Koizumi Y, Mikamo H.

J Infect Chemother. 2018 Sep;24(9):725-728. doi: 10.1016/j.jiac.2018.04.014.

PMID:
29773439
42.

Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.

Koizumi Y, Imadome KI, Ota Y, Minamiguchi H, Kodama Y, Watanabe D, Mikamo H, Uehira T, Okada S, Shirasaka T.

J Clin Immunol. 2018 May;38(4):478-483. doi: 10.1007/s10875-018-0500-4. Epub 2018 Apr 23.

PMID:
29687211
43.

Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.

Hirayama T, Miyazaki T, Yamagishi Y, Mikamo H, Ueda T, Nakajima K, Takesue Y, Higashi Y, Yamamoto Y, Kimura M, Araoka H, Taniguchi S, Fukuda Y, Matsuo Y, Furutani A, Yamashita K, Takazono T, Saijo T, Shimamura S, Yamamoto K, Imamura Y, Izumikawa K, Yanagihara K, Kohno S, Mukae H.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e02528-17. doi: 10.1128/AAC.02528-17. Print 2018 Jun.

44.

Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan.

Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, Iwata S, Kaku M, Hanaki H, Sumiyama Y, Kitagawa Y, Nakajima K, Ueda T, Uchino M, Mizuguchi T, Ambo Y, Konosu M, Ishibashi K, Matsuda A, Hase K, Harihara Y, Okabayashi K, Seki S, Hara T, Matsui K, Matsuo Y, Kobayashi M, Kubo S, Uchiyama K, Shimizu J, Kawabata R, Ohge H, Akagi S, Oka M, Wakatsuki T, Suzuki K, Okamoto K, Yanagihara K.

J Infect Chemother. 2018 May;24(5):330-340. doi: 10.1016/j.jiac.2018.02.011. Epub 2018 Mar 16. Erratum in: J Infect Chemother. 2018 Jul;24(7):592-595.

PMID:
29555391
45.

The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.

Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Nishiyama N, Koizumi Y, Yamagishi Y, Mikamo H.

J Infect Chemother. 2018 Jul;24(7):505-509. doi: 10.1016/j.jiac.2018.02.005. Epub 2018 Mar 13.

PMID:
29548627
46.

Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.

Mikamo H, Takesue Y, Iwamoto Y, Tanigawa T, Kato M, Tanimura Y, Kohno S.

J Infect Chemother. 2018 Jun;24(6):434-442. doi: 10.1016/j.jiac.2018.01.010. Epub 2018 Mar 9.

47.

Susceptibilities of epicardial and subcutaneous fat tissue for browning-gene expression and diet-induced volume reduction are different.

Mikamo H, Jiang M, Noro M, Suzuki Y, Hiruta N, Unoki-Kubota H, Schneider WJ, Bujo H.

Mol Med Rep. 2018 May;17(5):6542-6550. doi: 10.3892/mmr.2018.8690. Epub 2018 Mar 6.

48.

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist.

Shimizu K, Iiduka T, Sato S, Kiyokawa H, Nakagami T, Mikamo H, Kawazoe M, Takahashi M, Noro M.

Ther Clin Risk Manag. 2018 Feb 23;14:377-383. doi: 10.2147/TCRM.S153517. eCollection 2018.

49.

The Prophylactic Effect of Anti-influenza Agents for an Influenza Outbreak in a University Hospital.

Hagihara M, Kato Y, Kurumiya A, Takahashi T, Sakata M, Kato H, Sakanashi D, Yamada A, Suematsu H, Hirai J, Nishiyama N, Koizumi Y, Yamagishi Y, Mikamo H.

Intern Med. 2018;57(4):497-501. doi: 10.2169/internalmedicine.8854-17. Epub 2018 Feb 15.

50.

Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae.

Igawa G, Yamagishi Y, Lee KI, Dorin M, Shimuta K, Suematsu H, Nakayama SI, Mikamo H, Unemo M, Ohnishi M.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02069-17. doi: 10.1128/AAC.02069-17. Print 2018 Mar.

Supplemental Content

Loading ...
Support Center